Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by stockman75on Dec 02, 2016 8:33am
129 Views
Post# 25545108

RE:RE:RE:RE:Market still speaking !!

RE:RE:RE:RE:Market still speaking !!The comments on the board demonstrate clearly the market/shareholder typically has short term focus while management has a long term focus. In the end I am betting it management decisions will pay off and we will all be happy. It is very easy to play arm-chair quarterback... it is another thing to be the quarterback and run the team. I have been a long time shareholder and of course it can be frustrating at times but I am very pleased (to put mildly) with the current situation. 

Has thera management made mistakes? sure they have and they certainly are not perfect but I for one am not likely to consider selling until the story plays out. Only then will we understand some of these decisions. Looking back I am guessing we will all be pleased with the decision for the share offering or at minimum not really care too much!
Bullboard Posts